Pre hearing information
The Tribunal will inquire into the allegation that on 6 August 2015 Dr Coleridge Smith injected Fibrovein foam sclerosant directly into the supraorbital vein of Patient A (‘the Procedure’) when this was not appropriate. It is alleged that the Procedure was not in accordance with the indication for use; not in accordance with the extent of Fibrovein’s licence or in line with national guidance.
It is also alleged that Dr Coleridge Smith carried out the Procedure but failed to adequately assess and/or consider the physiological status of the venous system of the skull. It is further alleged that by carrying out the Procedure, Dr Coleridge Smith caused Patient A to develop permanent blindness in her left eye.
This reflects the allegation as it stands at the start of the hearing. The allegation may be amended as the hearing proceeds and when findings of fact are made by the tribunal.
All decisions are published online within 28 days of the conclusion of the hearing.
If you're a journalist and need up to date information about the allegation throughout the course of the hearing, please contact our press office at email@example.com or call 0161 250 6868.
In accordance with Rule 41(2) of the General Medical Council (Fitness to Practise) Rules 2004, the tribunal may decide to exclude the public from the proceedings or any part of the proceedings, where they consider that the circumstances of the case outweigh the public interest in holding the hearing in public.